Eastman Chemical Co.

As of October 24, 2025, Eastman Chemical Co. is considered overvalued with a P/E ratio of 16, a high PEG ratio of 3.28, and a year-to-date return of -31.34%, significantly underperforming compared to its peers and the S&P 500.

As of October 17, 2025, Eastman Chemical Co. is considered undervalued with a P/E ratio of 16, attractive compared to peers, and despite a recent 1Y return of -44.01%, it shows potential for recovery and growth.

As of October 17, 2025, Eastman Chemical Co. is considered an attractive investment due to its undervalued P/E ratio of 16 compared to peers, a strong ROE of 16.69%, and favorable valuation metrics despite a year-to-date stock decline of -32.90%.

As of October 17, 2025, Eastman Chemical Co. is considered undervalued with a P/E ratio of 16, an attractive EV to EBITDA ratio of 10.92, and a high dividend yield of 243.20%, despite a challenging year with a -44.01% return compared to the S&P 500's 14.08%.

As of October 3, 2025, Eastman Chemical Co. is considered overvalued with a P/E ratio of 16 and significant underperformance compared to the S&P 500, which raises concerns about its valuation outlook.

As of July 29, 2025, Eastman Chemical Co. is in a bearish trend, indicated by negative MACD, Bollinger Bands, and moving averages, with a year-to-date return of -27.22% compared to the S&P 500's 12.22%.

As of September 10, 2025, Eastman Chemical Co. is considered undervalued with a favorable valuation grade shift, featuring a P/E ratio of 16 and an EV to EBITDA ratio of 10.92, despite underperforming the S&P 500 with a year-to-date return of -27.22%.

As of January 31, 2025, Eastman Chemical Co. is considered undervalued with an attractive valuation grade, featuring a P/E ratio of 16, an EV to EBITDA of 10.92, and a high dividend yield of 243.20%, despite a year-to-date stock performance of -17.86% compared to the S&P 500's 2.44%.

As of June 13, 2025, Eastman Chemical Co. exhibits a bearish technical trend, supported by bearish MACD signals, negative moving averages, and bearish Bollinger Bands across multiple time frames.

As of March 2022, the management team of Eastman Chemical Co. is led by Mr. Mark Costa as Chairman and CEO, alongside independent directors Mr. Humberto Alfonso, Mr. Brett Begemann, Mr. Edward Doheny, Ms. Julie Holder, and Ms. Renee Hornbaker.

Eastman Chemical Company is a mid-cap firm in the Chemicals & Petrochemicals industry, specializing in advanced materials and specialty additives. As of March 2025, it reported net sales of $2.286 billion and a net profit of $183 million.

As of Jun 18, Eastman Chemical Co. has a market capitalization of $15.25 billion, with net sales of $9.35 billion and a net profit of $926 million for the latest four quarters.